Clinical trial
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia…
NCT00000597 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000597 |
|---|---|
| Title | Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Aplastic, Hematologic Diseases, Pancytopenia, Blood Disease |
| Intervention type | Drug |
| Interventions | antilymphocyte serum, nandrolone |
| Start date | Mar 1, 1982 |
| Completion | Dec 1, 1988 |
| First posted | Oct 28, 1999 |
| Last update posted | Nov 26, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: